Trusted Resources

Health System Barriers for Amyloidosis Patients

Clinical Diagnosis Guidelines for Transthyretin Amyloidosis

Amyloid Types

COVID-19 Resources | Patient Advocate Foundation

Specific Questions and Answers About COVID-19 for Transplant Patients

Recommendations of International Society of Amyloidosis on the Management of Patients with Systemic Amyloidosis During the COVID-19 Pandemic

How to Prepare Your Family in Case COVID-19 Spreads in Your Community – CDC

Subscribe to

Expert and Community Perspectives on Attruby®

In this special session, Dr. Barry Trachtenberg and members of the ATTR amyloidosis community came together to share medical insights and lived experiences related to Attruby™ (acoramidis). This expert-led discussion explores the clinical data, the patient perspective, and what lies ahead for those considering or currently taking Attruby.